Biology and therapy of inherited retinal degenerative disease: insights from mouse models
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Retinal neurodegeneration associated with the dysfunction or death of photoreceptors is a major cause of incurable vision loss. Tremendous progress has been made over the last two decades in discovering genes and genetic defects that lead to retinal diseases. The primary focus has now shifted to uncovering disease mechanisms and designing treatment strategies, especially inspired by the successful application of gene therapy in some forms of congenital blindness in humans. Both spontaneous and laboratory-generated mouse mutants have been valuable for providing fundamental insights into normal retinal development and for deciphering disease pathology. Here, we provide a review of mouse models of human retinal degeneration, with a primary focus on diseases affecting photoreceptor function. We also describe models associated with retinal pigment epithelium dysfunction or synaptic abnormalities. Furthermore, we highlight the crucial role of mouse models in elucidating retinal and photoreceptor biology in health and disease, and in the assessment of novel therapeutic modalities, including gene- and stem-cell-based therapies, for retinal degenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495 · cited 4×
“One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.”
InfluentialHartong, D. T., Berson, E. L., & Dryja, T. P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69740-7 · Cited by 2,924
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145 · cited 2×
“The first successful clinical example of such gene therapy came from LCA patients with congenital blindness caused by mutations in the RPE65 gene (Bainbridge et al., 2008; Cideciyan, 2010; Cideciyan et al., 2008; Maguire et al., 2008).”
BackgroundSelf-organizing optic-cup morphogenesis in three-dimensional culture
Eiraku, M., Takata, N., Ishibashi, H., Kawada, M., Sakakura, E., Okuda, S., Sekiguchi, K., Adachi, T., & Sasai, Y. (2011) · Nature · doi:10.1038/nature09941 · Cited by 2,001 · cited 1×
“With advances in stem-cell and iPSC technology, the first steps to emulate human disease in vitro are currently being taken using sophisticated culturing techniques (Eiraku et al., 2011; Nakano et al., 2012).”
BackgroundEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924 · cited 2×
“The first successful clinical example of such gene therapy came from LCA patients with congenital blindness caused by mutations in the RPE65 gene (Bainbridge et al., 2008; Cideciyan, 2010; Cideciyan et al., 2008; Maguire et al., 2008).”
BackgroundYang, H., Wang, H., Shivalila, C. S., Cheng, A. W., Shi, L., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.022 · Cited by 1,596 · cited 1×
“With the advent of new technologies, such as ‘clustered regularly interspaced short palindromic repeats’ (CRISPR) (Wang et al., 2013; Yang et al., 2013), we should be able to quickly produce mouse mutants with single- or even multi-gene defects.”
Self-formation of optic cups and storable stratified neural retina from human ESCs
Nakano, T., Ando, S., Takata, N., Kawada, M., Muguruma, K., Sekiguchi, K., Saito, K., Yonemura, S., Eiraku, M., & Sasai, Y. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.009 · Cited by 1,447 · cited 1×
“With advances in stem-cell and iPSC technology, the first steps to emulate human disease in vitro are currently being taken using sophisticated culturing techniques (Eiraku et al., 2011; Nakano et al., 2012).”
BackgroundAllikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435 · cited 3×
“Some cases of Stargardt disease follow autosomal dominant inheritance owing to mutations in ELOVL4 (elongation of very long chain fatty acids-like 4) (Allikmets, 1997; Zhang et al., 2001), which is required for the synthesis of very-long-chain fatty acids (Agbaga et al., 2008).”
BackgroundNachury, M. V., Loktev, A. V., Zhang, Q., Westlake, C. J., Peränen, J., Merdes, A., Slusarski, D. C., Scheller, R. H., Bazan, J. F., Sheffield, V. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.053 · Cited by 1,384 · cited 2×
“…of the BBSome, a component of the basal body that is involved in formation of the nonmotile primary cilium (see Box 1) (Kim et al., 2004; Nachury et al., 2007; Shah et al., 2008), and BBS6 is a component of the chaperonin complex (see Box 1) that is required for assembling the BBSome…”
BackgroundSchwartz, S. D., Regillo, C. D., Lam, B. L., Eliott, D., Rosenfeld, P. J., Gregori, N. Z., Hubschman, J.-P., Davis, J. L., Heilwell, G., Spirn, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61376-3 · Cited by 1,327 · cited 2×
“…led the way to the launching of a first-in-human clinical trial in which RPE cells derived from human embryonic stem cells were transplanted into the subretinal space of patients with AMD or Stargardt disease, and initial results appear promising (Schwartz et al., 2012; Schwartz et al., 2014).”
BackgroundMethodGene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202 · cited 1×
“…mouse (Redmond et al., 1998) and a naturally occurring Briard dog model of RPE65 disease were instrumental in developing this treatment, providing the opportunity to examine and prove safety and efficacy of the vectors prior to application in human patients (Acland et al., 2001; Pang et al., 2006).”
BackgroundDefective myosin VIIA gene responsible for Usher syndrome type IB
Well, D., Blanchard, S., Kaplan, J., Guilford, P., Gibson, F., Walsh, J., Mburu, P., Varela, A., Levilliers, J., Weston, M. D., et al. (1995) · Nature · doi:10.1038/374060a0 · Cited by 1,068
Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle
Redmond., T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J.-X., Crouch, R. K., & Pfeifer, K. (1998) · Nature Genetics · doi:10.1038/3813 · Cited by 929
Nrl is required for rod photoreceptor development
Mears, A. J., Kondo, M., Swain, P. K., Takada, Y., Bush, R. A., Saunders, T. L., Sieving, P. A., & Swaroop, A. (2001) · Nature Genetics · doi:10.1038/ng774 · Cited by 912
Self-citationWeng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881 · cited 1×
“The Abca4-KO mouse model has been utilized to understand the etiology of Stargardt disease (Weng et al., 1999).”
MethodRetinal degeneration mutants in the mouse
Chang, B., Hawes, N. L., Hurd, R. E., Davisson, M. T., Nusinowitz, S., & Heckenlively, J. R. (2002) · Vision Research · doi:10.1016/s0042-6989(01)00146-8 · Cited by 840
Self-citationMacLaren, R. E., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Seymour, L., Clark, K. R., During, M. J., Cremers, F. P. M., Black, G. C. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62117-0 · Cited by 796 · cited 1×
“The potential of gene therapy in the context of hereditary retinal disease is further highlighted by the recent report of treatment in patients with choroideremia, which is characterized by slow degeneration of the photoreceptors, RPE and choroid (see Box 1) (MacLaren et al., 2014).”
Gal, A., Li, Y., Thompson, D. A., Weir, J., Orth, U., Jacobson, S. G., Apfelstedt-Sylla, E., & Vollrath, D. (2000) · Nature Genetics · doi:10.1038/81555 · Cited by 679
Mutations in RPE65 cause autosomal recessive childhood–onset severe retinal dystrophy
Gu, S.-M., Thompson, D. A., Srikumari, C. R. S., Lorenz, B., Finckh, U., Nicoletti, A., Murthy, K. R., Rathmann, M., Kumaramanickavel, G., Denton, M. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-194 · Cited by 663 · cited 18×
“BBS, Bardet-Biedl syndrome; CD, cone dystrophy; CRD, cone-rod dystrophy; CSNB, congenital stationary night blindness; LCA, Leber congenital amaurosis; RP, retinitis pigmentosa.”
BackgroundInfluentialRIM1α forms a protein scaffold for regulating neurotransmitter release at the active zone
Schoch, S., Castillo, P. E., Jo, T., Mukherjee, K., Geppert, M., Wang, Y., Schmitz, F., Malenka, R. C., & Südhof, T. C. (2002) · Nature · doi:10.1038/415321a · Cited by 579 · cited 2×
“Mutations in RIMS1 cause autosomal dominant CRD (adCRD) (Johnson et al., 2003), and the Rims1-KO mouse indeed shows defects in neurotransmitter release (Schoch et al., 2002).”
BackgroundTranscriptional regulation of photoreceptor development and homeostasis in the mammalian retina
Swaroop, A., Kim, D., & Forrest, D. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2880 · Cited by 560
Self-citationRetinopathy induced in mice by targeted disruption of the rhodopsin gene
Humphries, M. M., Rancourt, D., Farrar, G. J., Kenna, P., Hazel, M., Bush, R. A., Sieving, P. A., Sheils, D. M., Creighton, P., Erven, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0297-216 · Cited by 529 · cited 1×
“…model demonstrated that a single copy of Rho is sufficient to drive both development and function of the ROS in mice, yet both alleles are required to maintain long-term functional D is ea se M od el s & M ec ha ni sm s integrity of the photoreceptors (Humphries et al., 1997; Lem et al., 1999).”
BackgroundSelf-citationHaider, N. B., Jacobson, S. G., Cideciyan, A. V., Swiderski, R., Streb, L. M., Searby, C., Beck, G., Hockey, R., Hanna, D. B., Gorman, S., et al. (2000) · Nature Genetics · doi:10.1038/72777 · Cited by 507 · cited 2×
“The disease is progressive, often leading to marked visual impairment in later stages (Haider et al., 2000; Jacobson et al., 2004; Wright et al., 2004).”
BackgroundPositional cloning of the gene associated with X-linked juvenile retinoschisis
Sauer, C. G., Gehrig, A., Warneke-Wittstock, R., Marquardt, A., Ewing, C. C., Gibson, A., Lorenz, B., Jurklies, B., & Weber, B. H. F. (1997) · Nature Genetics · doi:10.1038/ng1097-164 · Cited by 497 · cited 1×
“XLRS is caused by mutations in the retinoschisin gene (RS1) (Hiriyanna et al., 1999; Sauer et al., 1997).”
BackgroundIdelson, M., Alper, R., Obolensky, A., Ben-Shushan, E., Hemo, I., Yachimovich-Cohen, N., Khaner, H., Smith, Y., Wiser, O., Gropp, M., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.07.002 · Cited by 486 · cited 2×
“The attempts to differentiate cells that display morphological similarities and characteristics of RPE cells have gained momentum (Idelson et al., 2009; Klimanskaya et al., 2004; Vugler et al., 2008), and stem-cell-derived RPE has been transplanted into the subretinal space to slow the degeneration…”
BackgroundSelf-citationEffective gene therapy with nonintegrating lentiviral vectors
Yáñez-Muñoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1365 · Cited by 460 · cited 1×
“Lenti- and adenovirus-based vectors are also being investigated for gene delivery to the retina (Yáñez-Muñoz et al., 2006), but these do not seem to be very efficient in transducing photoreceptors (Puppo et al., 2014).”
BackgroundOlsson, J. E., Gordon, J. W., Pawlyk, B. S., Roof, D., Hayes, A., Molday, R. S., Mukai, S., Cowley, G. S., Berson, E. L., & Dryja, T. P. (1992) · Neuron · doi:10.1016/0896-6273(92)90236-7 · Cited by 455
Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells
Buchholz, D. E., Hikita, S. T., Rowland, T. J., Friedrich, A. M., Hinman, C. R., Johnson, L. V., & Clegg, D. O. (2009) · Stem Cells · doi:10.1002/stem.189 · Cited by 417
Hanein, S., Perrault, I., Gerber, S., Tanguy, G., Barbet, F., Ducroq, D., Calvas, P., Dollfus, H., Hamel, C., Lopponen, T., et al. (2004) · Human Mutation · doi:10.1002/humu.20010 · Cited by 350 · cited 3×
“Whereas R9AP and RGS9 mutations cause bradyopsia (see Box 1) (Nishiguchi et al., 2004b), GC1 mutations result in CD and LCA (Hanein et al., 2004).”
BackgroundPhotoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy
Bennett, J., Tanabe, T., Sun, D., Zeng, Y., Kjeldbye, H., Gouras, P., & Maguire, A. M. (1996) · Nature Medicine · doi:10.1038/nm0696-649 · Cited by 316
Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns
Rivolta, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.10.1219 · Cited by 296
Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy
Cideciyan, A. V. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.04.002 · Cited by 256
Van Hooser, J. P., Aleman, T. S., He, Y.-G., Cideciyan, A. V., Kuksa, V., Pittler, S. J., Stone, E. M., Jacobson, S. G., & Palczewski, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150236297 · Cited by 252 · cited 1×
“A better understanding of RPE65 as well as LRAT function in the visual cycle, based on data from mouse models (Van Hooser et al., 2000), has allowed development of a treatment for respective LCA patients based on supplementation of synthetic 9-cis retinoid (Koenekoop et al., 2014).”
BackgroundCiliary targeting motif VxPx directs assembly of a trafficking module through Arf4
Mazelova, J., Astuto‐Gribble, L., Inoue, H., Tam, B. M., Schonteich, E., Prekeris, R., Moritz, O. L., Randazzo, P. A., & Deretic, D. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.267 · Cited by 244
The RIM/NIM Family of Neuronal C2 Domain Proteins
Wang, Y., Sugita, S., & Südhof, T. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909008199 · Cited by 243 · cited 1×
“RIMS1 (regulating synaptic membrane exocytosis 1) is a RAB3A-interacting protein (Wang et al., 2000), and RAB3A is a synaptic-vesicle-associated protein involved in exocytosis.”
BackgroundAkhmedov, N. B., Piriev, N. I., Chang, B., Rapoport, A. L., Hawes, N. L., Nishina, P. M., Nusinowitz, S., Heckenlively, J. R., Roderick, T. H., Kozak, C. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5551 · Cited by 221 · cited 1×
“…M ec ha ni sm s of the function of NR2E3 and understanding of how mutations in this gene lead to ESCS came from analysis of a spontaneously arising mouse model, rd7, in which NR2E3 is mutated and the human phenotype is recapitulated (Akhmedov et al., 2000; Cheng et al., 2011; Peng et al., 2005).”
BackgroundSelf-citationVitamin A Metabolism in Rod and Cone Visual Cycles
Saari, J. C. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150748 · Cited by 189
Karan, G., Lillo, C., Yang, Z., Cameron, D. J., Locke, K. G., Zhao, Y., Thirumalaichary, S., Li, C., Birch, D. G., Vollmer-Snarr, H. R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407698102 · Cited by 182 · cited 1×
“Analysis of humanized transgenic mice expressing mutant ELOVL4 reveals that RPE atrophy and photoreceptor degeneration result from accumulation of phagosomes and lipofuscin (Karan et al., 2005; Vasireddy et al., 2006).”
BackgroundMolecular evolution of adeno-associated virus for enhanced glial gene delivery
Koerber, J. T., Klimczak, R., Jang, J.-H., Dalkara, D., Flannery, J. G., & Schaffer, D. V. (2009) · Molecular Therapy · doi:10.1038/mt.2009.184 · Cited by 181
Koenekoop, R. K., Sui, R., Sallum, J., van den Born, L. I., Ajlan, R., Khan, A., den Hollander, A. I., Cremers, F. P. M., Mendola, J. D., Bittner, A. K., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60153-7 · Cited by 103 · cited 2×
“, 2000), has allowed development of a treatment for respective LCA patients based on supplementation of synthetic 9-cis retinoid (Koenekoop et al., 2014).”
BackgroundRetinoschisin gene therapy in photoreceptors, Müller glia or all retinal cells in the Rs1h−/− mouse
Byrne, L. C., Öztürk, B. E., Lee, T., Fortuny, C., Visel, M., Dalkara, D., Schaffer, D. V., & Flannery, J. G. (2014) · Gene Therapy · doi:10.1038/gt.2014.31 · Cited by 96 · cited 5×
“Targeted expression of RS1 in the IS of photoreceptors via AAV vectors was capable of improving structure and function of the retina in this model (Byrne et al., 2014; Park et al., 2009).”
BackgroundInfluentialKoirala, A., Conley, S. M., Makkia, R., Liu, Z., Cooper, M. J., Sparrow, J. R., & Naash, M. I. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.299 · Cited by 47
Cited by
Cell Types of the Human Retina and Its Organoids at Single-Cell Resolution
Cowan, C. S., Renner, M., De Gennaro, M., Gross-Scherf, B., Goldblum, D., Hou, Y., Munz, M., Rodrigues, T. M., Krol, J., Szikra, T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.013 · Cited by 654
Dias, M. F., Joo, K., Kemp, J. A., Fialho, S. L., da Silva Cunha, A., Woo, S. J., & Kwon, Y. J. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.004 · Cited by 413
Lipid nanoparticles for delivery of messenger RNA to the back of the eye
Patel, S., Ryals, R. C., Weller, K. K., Pennesi, M. E., & Sahay, G. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.015 · Cited by 260
Molday, R. S., & Moritz, O. L. (2015) · Journal of Cell Science · doi:10.1242/jcs.175687 · Cited by 235
Pharmaceutical development of AAV-based gene therapy products for the eye
Rodrigues, G. A., Shalaev, E., Karami, T. K., Cunningham, J., Slater, N. K. H., & Rivers, H. M. (2019) · Pharmaceutical Research · doi:10.1007/s11095-018-2554-7 · Cited by 213
“to assess potential therapeutics, including gene therapy approaches (23).”
Background
Metadata
- Authors
- Veleri, S., Lazar, C. H., Chang, B., Sieving, P. A., Banin, E., & Swaroop, A.
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2015-02-01
- Volume
- 8
- Issue
- 2
- Pages
- 109-129
- ISSN
- 1754-8403 (ISSN-L)
- 1754-8411
- OpenAlex
- W2098642477
- Cited by
- 231
- References
- 42
- FWCI
- 9.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.